CLINICAL_TRIALS
trial_result
· 2019-03-13
Clinical Trial Update: A Study Of Galcanezumab In Participants With Episodic Cluster Headache [Phase 3]
Summary
Phase 3 trial results for galcanezumab in episodic cluster headache have been completed and results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Episodic Cluster Headache | Phase 3 | Status: COMPLETED | Results posted: 2019-03-13